Device Trial Radar · NCT03532347
Endoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study)
Last checked: Nov 20, 2026Latest source record: Jun 10, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
108
Actual
Start
May 22, 2017
Primary completion
May 4, 2018
Study completion Nov 4, 2018
Sponsor
- Lead sponsor
- Newcastle-upon-Tyne Hospitals NHS TrustAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medtronic
- First posted
- May 22, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study compares the diagnostic performance of Endoscopic ultrasound (EUS) guided fine needle aspiration and EUS guided core biopsy (SharkCore) in patients with a solid pancreatic mass.
Conditions
- Pancreas Cancer
- Pancreas Neoplasm, Benign
- Chronic Pancreatitis
- Pancreas Adenocarcinoma
Interventions
EUS-FNA needle (Beacon)Device
Participants will be randomised to an initial 3 passes with Beacon FNA and then Beacon SharkCore biopsy needles or vice versa. 25g needles will be used for trans duodenal puncture and 22g for trans gastric puncture.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The sensitivity of standard Beacon FNA needle compared with the SharkCore (FNB) core biopsy needle in the sampling of solid pancreatic mass lesions.Time frame: During EUS procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle, Newcastle Upon Tyne, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.